
Precision Medicine in Asthma and Eosinophilic Disorders
Overview
We are excited to host the first Precision Medicine in Asthma and Eosinophilic Disorders Symposium. This session is targeted for Fellows, Faculty of all levels and Advanced Practice Providers in the specialty areas of pulmonology and allergy/immunology. The session is facilitated by national thought leaders in their fields and the information presented will keep health team members current with the constantly evolving management guidelines. As evidenced by the agenda below, cutting edge topics within asthma and other eosinophilic disorders will be discussed. A strong focus on addressing the social determinants impacting clinical care will lead to rich discussions along with a ‘Meet the Professor’ session allowing for deeper conversations.
Commercial Support
This activity is sponsored by AstraZeneca Pharmaceuticals.
Target Audience
The target audience for this educational activity is Fellows, Junior Faculty and APP's in the specialty areas of pulmonology and allergy.
Learning Objectives
1| Discuss the various presentations of eosinophilic diseases
2| Describe the challenges in administering biologics to prevent atopic disorders.
3| Identify behavioral and environmental modifications that could be used to remediate eosinophilic disorders
Additional Information
Program
TIME | TITLE | SPEAKER |
12:00-12:30pm | Arrivals and Lunch |
|
100-110pm | Welcome and Sponsor introductions | Maureen Bauer, MD |
1:10-1:30pm | Winner of the Case Submission Contest - Interesting Eosinophilic Cases |
|
1:30-2:15pm | Biologic Therapies - who's a good candidate, then which biologic to select? | Bill Anderson, MD |
2:15-2:40pm | Does starting a biologic early have downstream impact of atopic disease | Stan Szefler, MD |
2:40-3:05pm | Health disparities in Asthma | Elizabeth Matsui, MD |
3:05-3:40pm | Break & Meet the Professor Session (2 tracks) |
|
3:45-4:10pmpm | Reframing Rescue Therapy to Help Prevent Asthma Exacerbations | Amanda Messinger, MD |
4:10-4:35 | Eosinophilic diseases beyond Asthma | Dan Atkins, MD |
4:35-5:00pm | Phenotyping in Asthma | Tony Gerber, MD |
5:15-6:00pm | Social Hour and Networking - Cocktails and Appetizers provided |
|
Venue
This course will take place in the Mt. Harvard Conference Room on the 2nd floor of Children's Hospital Colorado.
Faculty
Planning Committee:
Maureen Bauer, MD
Associate Professor of Pediatrics, University of Colorado School of Medicine
Fellowship Director - Allergy & Immunology
Children's Hospital Colorado
Stacey Martiniano, MD
Associate Professor of Pediatrics, University of Colorado School of Medicine
Fellowship Director - Pulmonology
Children's Hospital Colorado
Matthew Stern, MS
Manager, Continuing Medical Education
Children's Hospital Colorado
Stanley Szefler, MD
Professor of Pediatrics, University of Colorado School of Medicine
Research Medical Director and Director, Pediatric Asthma Research Program - The Breathing Institute
Interim Medical Director, Research Institute - Children's Hospital Colorado
Presenting Faculty:
William Anderson III, MD
Assistant Professor of Pediatric Allergy and Immunology
Co-Director Multidisciplinary Asthma Clinic (MAC)
University of Colorado
Associate Program Director, Allergy and Immunology Fellowship
Dan Atkins, MD
Associate Professor, Pediatrics-Allergy/Immunology
Co-Director, Gastrointestinal Eosinophilic Diseases Program
Children's Hospital Colorado
Elizabeth Matsui, MD, MHS
Professor of Population Health and Pediatrics, Dell Medical School
Director of Clinical and Translational Research
University of Texas - Austin
Amanda Messinger, MD
Associate Professor, Pediatrics-Pulmonary Medicine
Children's Hospital Colorado
Anthony Gerber, MD, PhD
Professor of Medicine, University of Colorado School of Medicine
National Jewish Health
Stanley Szefler, MD
Professor of Pediatrics, University of Colorado School of Medicine
Research Medical Director and Director, Pediatric Asthma Research Program - The Breathing Institute
Interim Medical Director, Research Institute - Children's Hospital Colorado
Accreditation
Medical
Children’s Hospital Colorado is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Children’s Hospital Colorado designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Others
A general certificate of attendance will be given to all other care providers.
Available Credit
- 4.50 AMA PRA Category 1 Credit™
- 4.50 Attendance
Exhibitors
This activity is sponsored by AstraZeneca Pharmaceuticals.